PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
Jun 1, 2024
PYC Therapeutics Ltd
Common Shares Outstanding
|
PYC Therapeutics Ltd
Common Shares Outstanding Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Common Shares Outstanding
AU$3.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
|
|
Immutep Ltd
ASX:IMM
|
Common Shares Outstanding
AU$1.2B
|
CAGR 3-Years
22%
|
CAGR 5-Years
29%
|
CAGR 10-Years
25%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Common Shares Outstanding
$1B
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Common Shares Outstanding
$483.1m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Common Shares Outstanding
AU$50.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Common Shares Outstanding
AU$323.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Common Shares Outstanding?
Common Shares Outstanding
3.7B
AUD
3.7B
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Common Shares Outstanding amounts to 3.7B AUD.
What is PYC Therapeutics Ltd's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
17%
17%
Over the last year, the Common Shares Outstanding growth was 17%. The average annual Common Shares Outstanding growth rates for PYC Therapeutics Ltd have been 5% over the past three years , 8% over the past five years , and 17% over the past ten years .
You don't have any saved screeners yet
